Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Flaxseed, Aromatase Inhibitors and Breast Tumor Characteristics (FABrC)

This study has been completed.
National Center for Complementary and Integrative Health (NCCIH)
Information provided by (Responsible Party):
Roswell Park Cancer Institute Identifier:
First received: February 7, 2008
Last updated: May 7, 2014
Last verified: May 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2014
  Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):